The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
Abstract
Selecting the appropriate approach for resection and follow-up of pheochromocytomas (PCCs) is highly dependent upon reliable localization and exclusion of multifocal, bilateral, or metastatic disease. Metaiodobenzylguanidine (MIBG) scintigraphy was developed for functional localization of catecholamine-secreting tissues. Somatostatin receptor imaging (SRI) has a high sensitivity for localizing head and neck paragangliomas, but studies of intraabdominal PCCs are rare. In this study we review our experience of [(123)I]MIBG and SRI, performed since 1983 and 1989, respectively, in the work-up of primary and recurrent PCCs. Scintigraphic results were correlated with catecholamine secretion, size and site, malignancy, associated tumor syndromes, and morphological features. [(123)I]MIBG scans were performed in a total of 75 patients, in 70 cases before resection of primary PCCs and in 5 cases because of recurrent disease. Ninety-one PCCs were resected. The overall detection rates were 83.3% and 89.8% for PCCs larger than 1.0 cm. Multifocal disease was detected in 4 patients with [(123)I]MIBG. [(123)I]MIBG uptake correlated with greater size of PCC (r = 0.33; P = 0.008) and greater concentration of plasma epinephrine (r = 0.32; P = 0.006). [(123)I]MIBG-negative PCCs (n = 14) had significantly (P = 0.01) smaller diameters than [(123I)]MIBG-positive tumors. Furthermore, [(123)I]MIBG uptake was significantly higher in unilateral (P = 0.02), benign (P = 0.02), sporadic (P = 0.02), intraadrenal (P = 0.02), and capsular invasive (P = 0.03) PCCs than in bilateral, malignant, MEN2A/2B-related, extraadrenal, and noninvasive PCCs, respectively. The detection rate of SRI was only 25% (8 of 32) for primary benign PCCs. In 14 patients metastases occurred, which were effectively visualized with [(123)I]MIBG in 8 of 14 cases. SRI was able to detect metastases in 7 of 8 cases, including 3 [(123)I]MIBG-negative metastatic cases. In addition, [(123)I]MIBG and SRI detected 2 recurrences. In conclusion, [(123)I]MIBG uptake is correlated with the size, epinephrine production, and site of PCCs. Its role in bilateral and MEN2A/2B-related PCCs seems limited. In cases of recurrent elevation of catecholamines, localization of metastases and/or recurrence should be attempted with [(123)I]MIBG scintigraphy. In suspicious metastatic PCCs, SRI might be considered to supplement [(123)I]MIBG scintigraphy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
Scintigraphic Localization of Pheochromocytoma
Sisson, J. C., Frager, M. S., Valk, T. W., Gross, M. D., Swanson, D. P., Wieland, D. M., Tobes, M. C., Beierwaltes, W. H., & Thompson, N. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050103 · Cited by 544
Extra-Adrenal Pheochromocytoma
Whalen, R. K., Althausen, A. F., & Daniels, G. H. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37119-7 · Cited by 452
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Early experience with laparoscopic approach for adrenalectomy.
Gagner, M., Lacroix, A., Prinz, R. A., Bolté, E., Albala, D., Potvin, C., Hamet, P., Kuchel, O., Quérin, S., & Pomp, A. (1993) · PubMed · Cited by 380
Shapiro, B., Copp, J., Sisson, J. C., Eyre, P., Wallis, J. W., & Beierwaltes, W. H. (1985) · PubMed · Cited by 344
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Current Management of Pheochromocytoma
REMINE, W. H., CHONC, G. C., VAN HEERDEN, J. A., SHEPS, S. G., & HARRISON, E. G. (1974) · Annals of Surgery · doi:10.1097/00000658-197405000-00029 · Cited by 299
Eisenhofer, G., Keiser, H., Friberg, P., Mezey, E., Huynh, T.-T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A., & Lenders, J. W. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4870 · Cited by 242
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
Krenning, E. P., de Jong, M., Kooij, P. P. M., Breeman, W. A. P., Bakker, W. H., de Herder, W. W., van Eijck, C. H. J., Kwekkeboom, D. J., Jamar, F., Pauwels, S., et al. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s23 · Cited by 234
Self-citationPheochromocytoma: current status and changing trends.
van Heerden, J. A., Sheps, S. G., Hamberger, B., Sheedy, P. F., Poston, J. G., & ReMine, W. H. (1982) · PubMed · Cited by 233
Carney, J. A., Sizemore, G. W., & Sheps, S. G. (1976) · American Journal of Clinical Pathology · doi:10.1093/ajcp/66.2.279 · Cited by 227
van der Hoorn, F. A. J., Boomsma, F., Man In't Veld, A. J., & Schalekamp, M. A. D. H. (1989) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83003-0 · Cited by 224
Self-citationManagement of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes
Lairmore, T. C., Ball, D. W., Baylin, S. B., & Wells, S. A. (1993) · Annals of Surgery · doi:10.1097/00000658-199306000-00001 · Cited by 218
de Jong, M., Breeman, W. A., Bakker, W., Kooij, P. P. M., Bernard, B. F., Hofland, L. J., Visser, T. J., Srinivasan, A., Schmidt, M. A., Erion, J. L., et al. (1998) · PubMed · Cited by 209
Self-citationOctreotide scintigraphy for the detection of paragangliomas.
Kwekkeboom, D. J., van Urk, H., Pauw, B. K. H., et al. (1993) · PubMed · Cited by 168
Self-citationWieland, D. M., Brown, L. E., Tobes, M. C., Rogers, W. L., Marsh, D. D., Mangner, T. J., Swanson, D. P., & Beierwaltes, W. H. (1981) · PubMed · Cited by 164
Jalil, N. D., Pattou, F. N., Combemale, F., Chapuis, Y., Henry, J., Peix, J., & Proye, C. A. G. (2002) · The European Journal of Surgery · doi:10.1080/110241598750004913 · Cited by 153
[Endoscopic, retroperitoneal adrenalectomy].
Walz, M., & Giebler, R. M. (1997) · PubMed · Cited by 153
Comparison of three techniques for adrenalectomy
Bonjer, H. J., Lance, J. F., Geert Kazemier, M., de Herder, W. W., Steyerberg, E. W., & Bruining, H. A. (1997) · British journal of surgery · doi:10.1046/j.1365-2168.1997.02655.x · Cited by 152
Self-citationTenenbaum, F., Lumbroso, J., Schlumberger, M. J., Mure, A., Plouin, P., Caillou, B., & Parmentier, C. (1995) · PubMed · Cited by 139
MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION
Shapiro, B., Sisson, J. C., LLOYD, R., Nakajo, M., SATTERLEE, W. G., & Beierwaltes, W. H. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00074.x · Cited by 131
Furuta, N., Kiyota, H., Yoshigoe, F., Hasegawa, N., & Ohishi, Y. (1999) · International Journal of Urology · doi:10.1046/j.1442-2042.1999.06310.x · Cited by 114
Lynn, M. D., Shapiro, B., Sisson, J. C., et al. (1985) · Radiology · doi:10.1148/radiology.155.3.4001380 · Cited by 102
The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma.
Mozley, P. D., Kim, C. K., Mohsin, J., Jatlow, A. D., Gosfield, E., & Alavi, A. A. (1994) · PubMed · Cited by 101
Webb, T. A., Sheps, S. G., & Carney, J. A. (1980) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198004000-00003 · Cited by 92
Epelbaum, J., Bertherat, J. Y., Prevost, G. P., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D., & Plouin, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1837 · Cited by 92
Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
Sisson, J. C., & Shulkin, B. L. (1999) · PubMed · Cited by 79
Eisenhofer, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2175 · Cited by 74
Kopf, D., Bockisch, A., Steinert, H. C., Hahn, K. M., Beyer, J., Neumann, H. P. H., Hensen, J., & Lehnert, H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1738.x · Cited by 69
Use of 131I-MIBG Scintigraphy in the Evaluation of Suspected Pheochromocytoma
Swensen, S. J., Brown, M. L., Sheps, S. G., et al. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60536-9 · Cited by 65
Plouin, P., Bertherat, J. Y., Chateiller, O., Billaud, E. M., Azizi, M., Grouzmann, E., & Epelbaum, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01877.x · Cited by 51
Pattou, F. N., Combemale, F., Poirette, J.-F., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80047-x · Cited by 41
Retroperitoneal Adrenalectomy: Open or Endoscopic?
Bonjer, H. J., van der Harst, E., Steyerberg, E. W., de Herder, W. W., Geert Kazemier, M., Mohammedamin, R. S. A., & Bruining, H. A. (1998) · World Journal of Surgery · doi:10.1007/s002689900553 · Cited by 36
Self-citationValidation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine Tumors
Lamberts, S. W. J., Reubi, J., & Krenning, E. P. (1993) · Acta Oncologica · doi:10.3109/02841869309083907 · Cited by 32
Self-citationBruining, H. A., Lamberts, S. W. J., Eg, O., & van Seyen, A. J. (1984) · PubMed · Cited by 30
Self-citationThe role of radiolabeled somatostatin analogs in adrenal imaging
Maurea, S., Lastoria, S., Caracò, C., Klain, M., Varrella, P., Acampa, W., Muto, P., & Salvatore, M. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00065-0 · Cited by 29
Pheochromocytoma due to unilateral adrenal medullary hyperplasia
Qupty, G., Ishay, A., Peretz, H., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2841134.x · Cited by 21
Adrenal Medullary Hyperplasia: Hyperplasia‐pheochromocytoma Sequence
Kurihara, K., Mizuseki, K., Kondo, T., et al. (1990) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1990.tb01616.x · Cited by 20
Schnakenburg, K. V., M�ller, M., D�rner, K., Harms, D., Schwarze, E. ‐., Grosse, F. R., & Wiedemann, H. ‐. (1976) · European Journal of Pediatrics · doi:10.1007/bf00481506 · Cited by 19
Locating Pheochromocytomas by Scintigraphy Using 131I-Metaiodobenzylguanidine
Sisson, J. C., Shapiro, B., Beierwaltes, W. H., et al. (1984) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.34.2.86 · Cited by 18
Computed Tomography and 131 I-MIBG Scintigraphy in the Diagnosis of Pheochromocytoma
Koizumi, M., Endo, K., Sakahara, H., et al. (1986) · Acta Radiologica Diagnosis · doi:10.1177/028418518602700310 · Cited by 13
Cited by
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A.-P., Grossman, A. B., Kimura, N., Mannelli, M., McNicol, A. M., & Tischler, A. S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0396 · Cited by 680
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Chen, H., Sippel, R. S., O'Dorisio, M. S., Vinik, A. I., Lloyd, R. V., & Pacak, K. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb4f0 · Cited by 593
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
Korner, M., Stockli, M., Waser, B., & Reubi, J. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038679 · Cited by 477
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Kwekkeboom, D. J., Kam, B. L., van Essen, M., Teunissen, J. J. M., van Eijck, C. H. J., Valkema, R., de Jong, M., de Herder, W. W., & Krenning, E. P. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0078 · Cited by 466
Self-citation
Metadata
- Authors
- van der Harst, E., de Herder, W. W., Bruining, H. A., Bonjer, H. J., de Krijger, R. R., Lamberts, S. W. J., van de Meiracker, A. H., Boomsma, F., Stijnen, T., Krenning, E. P., Bosman, F. T., & Kwekkeboom, D. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-02
- Volume
- 86
- Issue
- 2
- Pages
- 685-693
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2121925788
- Cited by
- 253
- References
- 44
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.